专利检索 ap:("MITSUBISHI PHARMA CORP") AND inv:"TANAKA TADASHI" 第 1 页

1.

发明公开
DRUGS COMPRISING COMBINATION OF ANTITHROMBOTIC AGENT WITH PYRAZOLONE DERIVATIVE 有权
标题翻译： WITH A抗血小板药物的组合以及吡唑酮衍生物药物

公开(公告)号：EP1437137A4

公开(公告)日：2006-05-10

申请号：EP02760833

申请日：2002-09-13

申请人： MITSUBISHI PHARMA CORP

发明人： YAMADA KEIICHI , KURITA KATSUMI , TANAKA TADASHI , TANAKA MASAHIKO , EGUCHI JYUNICHI , YUKI SATOSHI , YOSHII NARIHIKO

IPC分类号： A61K31/415 , A61K45/06 , A61P9/10 , C07D231/20 , C07D231/22 , C07D231/26 , C07D231/28 , C07D231/56 , A61K31/4545 , A61K45/00 , A61P7/02

CPC分类号： C07D231/56 , A61K31/415 , A61K31/4174 , A61K31/4545 , C07D231/20 , C07D231/22 , C07D231/26 , C07D231/28 , A61K2300/00

摘要： It is intended to provide drugs for treating and/or preventing ischemic diseases which are safe and have little side effects. Namely, drugs comprising a combination of an antithrombotic agent and a pyrazolone derivative defined in the description or its pharmaceutically acceptable salt.